Methods to cause tissue, such as mucosal cells, to express increased amounts of bactericidal permeability increasing protein (BPI) are described. The BPI inducing agents include, for example, lipoxin compounds.

Claims

4 · 1 independent · depth 3

4 granted claims

›1.independentA method to treat sepsis in a subject, comprising the step of administering to a subject infected with sepsis a therapeutically effective amount of a …+3

Classifications

8 codes

IPC · International Patent Classification

Section A — Human necessities

A01N37/00
A61K31/215
A61K31/22
A61K31/23
A01N37/02

USPC · US Patent Classification

514/552514/529514/546

Claim changes

Soon

Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency

3.6 y

1,324 days filing → grant

Office actions

after a restriction

Responses

1 RCE

Interviews

examiner interview summaries

Examiner

Yong S. Chong

art unit 1627 · TC 1600

Law firm

Law firm · Log in to unlock

Citations: 137 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Priority chain

2 priority documents

Priority

18 Dec 2001

earliest claimed

›Priority documents — 2

Type	Document	Date
provisional	US 60342138	18 Dec 2001
related publication	US 20080214665 A1	4 Sep 2008

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.